We found that CPT alleviated the CUS induced depression-related phenotypes by promoting neurogenesis and BDNF/TrkB signaling and inhibiting microglial activation and the release of proinflammatory factors in CUS mice. This evidence concerns the gene NTRK2 and depressive symptom measurement.